These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11274927)
1. VAP-1: an adhesin and an enzyme. Salmi M; Jalkanen S Trends Immunol; 2001 Apr; 22(4):211-6. PubMed ID: 11274927 [TBL] [Abstract][Full Text] [Related]
2. A cell surface amine oxidase directly controls lymphocyte migration. Salmi M; Yegutkin GG; Lehvonen R; Koskinen K; Salminen T; Jalkanen S Immunity; 2001 Mar; 14(3):265-76. PubMed ID: 11290336 [TBL] [Abstract][Full Text] [Related]
3. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Kivi E; Elima K; Aalto K; Nymalm Y; Auvinen K; Koivunen E; Otto DM; Crocker PR; Salminen TA; Salmi M; Jalkanen S Blood; 2009 Dec; 114(26):5385-92. PubMed ID: 19861682 [TBL] [Abstract][Full Text] [Related]
4. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Jaakkola K; Nikula T; Holopainen R; Vähäsilta T; Matikainen MT; Laukkanen ML; Huupponen R; Halkola L; Nieminen L; Hiltunen J; Parviainen S; Clark MR; Knuuti J; Savunen T; Kääpä P; Voipio-Pulkki LM; Jalkanen S Am J Pathol; 2000 Aug; 157(2):463-71. PubMed ID: 10934150 [TBL] [Abstract][Full Text] [Related]
5. Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation. Salmi M; Jalkanen S Antioxid Redox Signal; 2019 Jan; 30(3):314-332. PubMed ID: 29065711 [No Abstract] [Full Text] [Related]
6. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress. Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025 [TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. Tohka S; Laukkanen M; Jalkanen S; Salmi M FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375 [TBL] [Abstract][Full Text] [Related]
9. Endothelial amine oxidase AOC3 transiently contributes to adaptive immune responses in the airways. Dunkel J; Aguilar-Pimentel JA; Ollert M; Fuchs H; Gailus-Durner V; de Angelis MH; Jalkanen S; Salmi M; Veres TZ Eur J Immunol; 2014 Nov; 44(11):3232-9. PubMed ID: 25116373 [TBL] [Abstract][Full Text] [Related]
10. Functional modulation of vascular adhesion protein-1 by a novel splice variant. Kaitaniemi S; Grön K; Elovaara H; Salmi M; Jalkanen S; Elima K PLoS One; 2013; 8(1):e54151. PubMed ID: 23349812 [TBL] [Abstract][Full Text] [Related]
11. Induction and function of vascular adhesion protein-1 at sites of inflammation. Salmi M; Kalimo K; Jalkanen S J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796 [TBL] [Abstract][Full Text] [Related]
12. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Salmi M; Tohka S; Jalkanen S Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915 [TBL] [Abstract][Full Text] [Related]
13. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345 [TBL] [Abstract][Full Text] [Related]
14. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Jalkanen S; Salmi M Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):18-26. PubMed ID: 17962625 [TBL] [Abstract][Full Text] [Related]
15. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Stolen CM; Marttila-Ichihara F; Koskinen K; Yegutkin GG; Turja R; Bono P; Skurnik M; Hänninen A; Jalkanen S; Salmi M Immunity; 2005 Jan; 22(1):105-15. PubMed ID: 15664163 [TBL] [Abstract][Full Text] [Related]
16. [Vascular adhesion protein-1 (VAP-1) in inflammatory process]. Pietruczuk M; Pietruczuk A; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T Przegl Lek; 2006; 63(4):220-2. PubMed ID: 17083159 [TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. Salmi M; Jalkanen S Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control. Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057 [TBL] [Abstract][Full Text] [Related]
19. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. Jaakkola K; Jalkanen S; Kaunismäki K; Vänttinen E; Saukko P; Alanen K; Kallajoki M; Voipio-Pulkki LM; Salmi M J Am Coll Cardiol; 2000 Jul; 36(1):122-9. PubMed ID: 10898423 [TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. Marttila-Ichihara F; Castermans K; Auvinen K; Oude Egbrink MG; Jalkanen S; Griffioen AW; Salmi M J Immunol; 2010 Mar; 184(6):3164-73. PubMed ID: 20154208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]